Angela Bradbury

Angela Bradbury, MD is an Innovation Faculty member at the Penn Center for Cancer Care Innovation (PC3I), Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania, and Professor of Medicine in Medical Ethics and Health Policy at the Perelman School of Medicine. She is an NIH-funded physician-scientist focused on ELSI (ethical, legal and social implications of genetic medicine) and the clinical implementation of genetic medicine who founded a novel nationwide Telegenetics Program, serving as a model for telehealth services and genetic delivery research. Her team empirically developed communication protocols for remote telephone and videoconferencing services, as well as the tiered-binned model for pre-test genetic counseling for multi-gene germline testing. She has conducted multiple large randomized trials evaluating outcomes of telehealth and remote services delivered in community practices and the home.

In 2012, she founded the Penn Telegenetics Program, a national leader in telehealth services and research for genetic medicine. This work began with a focus on cancer, but now includes remote telehealth services across multiple areas of genetic medicine (neurology, cardiology and medical genetics) through clinical contracts, national cohorts, national clinical trials and NIH grants. She has led multiple studies evaluating return of genetic research results and has demonstrated that digital tools can assist with pre-disclosure education with similar patient outcomes. Her current studies are evaluating a range of digital tools in delivery of genetic services and return of genetic research results including web-based multi-media interventions, chatbots and the use of Artificial intelligence to reduce provider time and improve patient outcomes. She was elected to the American Society for Clinical Investigation in 2024 as a leader in telehealth, health services and ELSI research.

Prior to her current roles, Dr. Bradbury earned her bachelor’s degree in biology at the University of Virginia and her medical degree at the University of South Carolina before completing her residency and fellowships in medical oncology and clinical medical ethics (MacLean Center) at the University of Chicago.